ML Mastery Monday ??: Your Weekly Dose of AI Excellence!

We're passionate about keeping you informed on the latest and greatest in the industry, ensuring you never miss a beat in this rapidly evolving space. Here's what happened in the Artificial Intelligence (AI) and Machine Learning (ML) space this week.

Top Headlines

India Adopts AI Tool to Build Language Dataset

India is using AI to create its first chatbot for Tuberculosis, with villagers in Karnataka contributing to a unique language dataset project. Over 40 million native Kannada speakers participated by reading sentences into a dedicated app. This project aims to address the lack of coverage for Indian languages, like Kannada, in natural language processing, limiting access to information for millions. Villagers contribute speech data for tech firm Karya, supporting the development of AI models for education and healthcare. How can AI tools be made accessible to those who don't speak major languages? Read ahead to know more!

==========

AUKUS to Use AI to Assist in Submarine Tracking

AUKUS, comprising Australia, the US, and the UK, is using AI to revolutionize submarine tracking for enhanced maritime security. The defense ministers of the three nations commit to leveraging AI on Australia's P-8A maritime patrollers to collect and process sonobuoy data, boosting anti-submarine warfare capabilities. The Resilient and Autonomous Artificial Intelligence Technologies (RAAIT) program, integrating AI and machine learning, is set for operational deployment in 2024. What are the broader implications for maritime security? Read ahead to know more!

==========

AstraZeneca and AI Biologics Join Hands to Develop Cancer Drug

AstraZeneca, a leading pharmaceutical company, is partnering with Absci Corporation, a U.S.-based generative artificial intelligence (GenAI) biologics firm, in a $247 million collaboration for revolutionary cancer therapeutics. Absci's GenAI platform, using a unique "zero-shot" approach, designs antibodies without relying on known data, integrating AI and wet-lab validation. AstraZeneca aims to accelerate cancer drug discovery, leveraging Absci's platform to shorten development timelines from six years to 18-24 months. How does the collaboration contribute to the acceleration of cancer drug discovery? Read ahead to know more!

==========

Open AI to Buy AI Chips Worth $51 Million From Startup Rain, Backed by Altman

OpenAI is set to invest $51 million in Rain AI, a startup specializing in neuromorphic processors (NPUs) called "Digital Dendrites." These processors emulate the human brain's structure and offer promising solutions for the computational demands of AI tasks with minimal power consumption. Rain AI, founded in 2017, claims its NPUs could outperform traditional GPUs by 100 times in power and 10,000 times in energy efficiency. Despite challenges and competition, Rain AI has garnered support from influential investors. What impact might OpenAI's investment have on the AI hardware landscape? Read ahead to know more!

==========

AI Can Find Audit Frauds - EY

Ernst & Young (EY), a global professional services firm, has embraced artificial intelligence (AI) to transform its audit processes, successfully detecting fraudulent activities. The firm's proprietary application, EY Canvas, developed with Microsoft, empowers auditors to create unified audit plans globally, providing real-time monitoring and flexibility. Despite industry skepticism, EY's transparent approach and early success in detecting fraud highlight the potential of AI in reshaping financial professions. What are the challenges and benefits associated with integrating AI into auditing? Read ahead to know more!